First-in-human phase I/II study of NEOD001 in patients with light chain amyloidosis and persistent organ dysfunction - Gertz, Morie A.; Landau, Heather; Comenzo, Raymond L.; Seldin, David; Weiss, Brendan; Zonder, Jeffrey; Merlini, Giampaolo; Schönland, Stefan; Walling, Jackie; Kinney, Gene G.; Koller, Martin; Schenk, Dale B.; et al. (Journal of clinical oncology, 2016)
Gesehen am 04.06.2020